Ahmet Tezel serves as the Chief Innovation Officer at LivaNova PLC, a global medical technology company focused on advancing therapies for cardiovascular and neuromodulation disorders. With a robust background in engineering and innovation, Tezel has been instrumental in driving LivaNova's mission to improve patient outcomes through cutting-edge medical technologies. Prior to joining LivaNova, he held significant roles at major medical device companies, where he spearheaded numerous successful product developments and strategic initiatives. In his current role at LivaNova, Tezel is responsible for overseeing the company's innovation strategy, which includes identifying new opportunities for growth and ensuring the successful development and commercialization of new products. His leadership has been pivotal in fostering a culture of innovation within the organization, encouraging cross-functional collaboration and the integration of advanced technologies into LivaNova's product portfolio. Under his guidance, LivaNova has achieved several milestones, including the launch of groundbreaking solutions that have significantly improved the quality of life for patients worldwide. Tezel's achievements extend beyond his corporate role; he is also recognized in the industry for his contributions to medical technology advancements. He has authored numerous publications and holds several patents, reflecting his commitment to advancing the field. His visionary approach and dedication to innovation continue to position LivaNova as a leader in the medical technology sector, driving the company toward a future where patients can benefit from the latest advancements in healthcare.